OVARIAN CANCER and US: presentation

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label presentation. Show all posts
Showing posts with label presentation. Show all posts

Monday, August 29, 2011

Selected References 'PRO' Presentation: Carolyn Benivegna - Ovarian Cancer Survivors' Debate (previously unpublished)



SELECTED REFERENCES



National Ovarian Cancer Coalition (NOCC)
561.393.0005

Ovarian Cancer National Alliance (OCNA)
202.331.1332

Ovar’coming Together
317.925.6643

Ovarian Cancer Alliance of Florida-Gulf Coast
(OCAF-GC)
239.455.0554

FORCEFacing Our Risk of Cancer Empowered
Re. hereditary breast and ovarian cancer
954.255.8732

SHARE
Providing survivor-led support for those with breast or ovarian cancer
212.719.0364

Gilda’s  Club
Provides meeting place for people with cancer for emotional support & networking
888.GILDA-4-U (888.445.3248)

National Ovarian Cancer Association (Canada)
416.962.2700 or toll-free 877.413.7970

Ovarian Cancer Canada (OCA)
800.749.9310 or 604.676.3431

Canada Cancer Society
858.795.3111

National Cancer Institute of Canada (NCIC)
416.961.7223

Sandi Pniauskas

Carolyn Benivegna


Gynecologic Cancer Foundation (GCF)
Promotes public awareness about the prevention, early detection and treatment of gynecologic cancers.
312.578.1439

Allied Support Group
Part of GCF; mission is to facilitate synergy between organizations who share the goals of the prevention and early detection of gynecologic cancers, and of optimizing the care of women living with these malignancies.  
312.578.1439

National Cancer Institute (NCI)
Part of National Institutes of Health (NIH)
800-4-CANCER (800.422.6237) or 800.332.8615

R. Kevin Reynolds, M.D., FACOG, FACS
Chief, Division of Gynecologic Oncology
University of Michigan Comprehensive Cancer Center
734.936.6886

James W. Orr, Jr., M.D., FACOG, FACS
Past President of Society of Gynecologic Oncologists
Medical Director of Florida Gynecologic Oncology and
Lee Cancer Care
800.874.7502 and 239.334.6626
  
Canadian Partnership Against Cancer

National Cancer Institute of Canada

Canadian Institute for Health Research

Clinical Trials by University/Organization

PubMed (to do searches)

CANADIAN HEALTH NETWORK
Complimentary and Alternative Health Resources (Canada)
or

Tuesday, May 24, 2011

Comment from affiliated blog: Survivors' Debate - CANO presentation



posted comment:

arizona cancer treatment said...
Well explained. I am a researcher and these details were lot helpful for my research. Thanks for sharing. Stay in touch and keep posting.

Friday, January 14, 2011

Perspectives 2011: Key to Ovarian Cancer Detection - the Endocrine Society Research Affairs Endocrine News Jan 2011 Dr Lee (Chicago)





Perspective: Dr Lee (Chicago)

"About This Series
For the Bi-Point/Tri-Point perspective series of articles in Endocrine News, the topics, authors, and outside reviewers are selected by The Endocrine
Society’s Research Affairs Core Committee to explore subject areas from different angles. The authors write their articles independently and the drafts are then reviewed by contributing co-editors and by independent experts in the specific topic area.
If you have any comments about this feature, please email
endocrinenews@endo-society.org.
For archived copies of this series on more than 26 topics, please visit the
Endocrine News Web site, www.endo-society.org/endo_news/index.cfm"

2011 (pdf/slides) Screening for Ovarian Cancer - University of Manitoba - Dr Lotocki



Epithelial Ovarian Cancer
Cancer Day for Primary Care
Friday, January 14, 2011

Wednesday, September 22, 2010

full free access: eMJA: Pathways to the diagnosis of epithelial ovarian cancer in Australia



Note: excerpts below,  the tables included in the paper provide interesting information including patients with borderline tumours, 24% of patients in this study had a prior hysterectomy  etc...

Objective:
To describe the diagnostic pathways experienced by a large, representative group of Australian women with ovarian cancer, and to document the time between first presentation to a medical professional and clinical diagnosis.

Main outcome measures:
Number and type of doctors consulted, investigations performed, referral patterns and the time from first presentation to diagnosis.
Conclusions:
Despite anecdotal suggestions to the contrary, most women with ovarian cancer in Australia are investigated and diagnosed promptly. The diagnostic process is more protracted for a minority of women, and the factors we found to be associated with diagnostic delay warrant further investigation.

"........The numbers of symptoms reported, doctors seen and total doctor visits were all highly skewed. These variables were therefore summarised....."